PharmaShots | Incisive News in 3 Shots

Subscribe Now

Takeda’s Hyqvia

Takeda’s Hyqvia Receives the US FDA’s sBLA Approval for the Treatment of Childrens with Primary Immunodeficiency

Takeda’s Hyqvia Receives the US FDA’s sBLA Approval for the Treatment of Childrens with Primary Immunodeficiency

April 12, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us